Oxygen Concentrators Market By Product Type (Portable Oxygen Concentrators (POC), Stationary Oxygen Concentrators), By Technology (Continuous Flow, Pulse Dose, Dual Flow), By Delivery System (Compressed Gas Systems, Liquid Oxygen Systems, Oxygen Concentrator Systems), By Power Source (Electric Powered, Battery Powered, Solar Powered), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Respiratory Distress Syndrome, Pneumonia, Cystic Fibrosis, Other Respiratory Conditions), By End User (Hospitals, Homecare Settings, Ambulatory Surgical Centers, Long-Term Care Facilities, Military & Emergency Services), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

---

Industry Outlook

The Oxygen Concentrators Market accounted for USD 3.74 Billion in 2024 and USD 3.95 Billion in 2025 and is expected to reach USD 6.77 Billion by 2035, growing at a CAGR of around 5.54% between 2025 and 2035. An oxygen concentrator offers purified oxygen to people with chronic obstructive pulmonary disease (COPD), asthma and other conditions that reduce blood oxygen levels. Rather than simply storing oxygen, these machines use air around the patient, concentrate it and then deliver it to them through a mask or cannula. The sales of oxygen concentrators have increased because more people face respiratory diseases, are learning about home healthcare and traders introduce better portable solutions. The pandemic increased the need for these which demonstrated their key role in both urgent and continued medical care. Because more elderly people need home therapy, sales of oxygen concentrators are rising as they are critical to care at home.

Industry Experts Opinion

“People may have bought oxygen concentrators in a hurry, but I don’t think they will become a product category that will be regularly used.”

• Anil Bhasin, Former President of Havells (Consumer Durables Industry Veteran)

Report Scope:

Market Dynamics

Increasing prevalence of respiratory disorders such as COPD and asthma is driving the demand for oxygen concentrators globally.

An increasing number of COPD and asthma cases are pushing up the demand for oxygen concentrators around the globe. Many people from around the globe have these ongoing airway conditions and they often need oxygen therapy for a long time to help maintain healthy oxygen levels. Patients can count on oxygen concentrators to provide steady and practical oxygen at both home and while travelling. Since air pollution, smoking and an older population are growing, there are now more people developing respiratory illnesses. This rise in respiratory diseases is increasing the demand for oxygen concentrations that improve a person’s life and help cut back on hospital visits.

Because healthcare is moving toward home-based services, oxygen concentrators are now often relied upon to treat chronic lung diseases at home. COPD and asthma patients are often short of breath and tired because of low blood oxygen levels and an oxygen concentrator helps give them a regular supply of oxygen, easing their symptoms. Elderly patients and anyone hoping for more independence are drawn to glucose monitors for how easy they are to use and the fact that they are portable and not invasive. Better knowledge of the advantages of oxygen therapy, plus changes in oxygen concentrators, have made their use more frequent. Because of this, a rise in respiratory illnesses is increasing the demand for oxygen concentrators, encouraging manufacturers to invent new models and improve their products.

The growing elderly population is boosting the use of home-based oxygen therapy solutions.

Because more people are ageing, there is a rising need for home-based oxygen therapy, with oxygen concentrators leading the way. As individuals age, they often suffer from chronic cases of COPD, emphysema and similar lung problems that may need them to always receive oxygen. Older individuals often like treatments that let them stay home rather than go to hospitals or nursing homes. Oxygen concentrators are comfortable to use and are simple to set up at home. These devices allow senior people to continue breathing easily so they can keep moving on their own and deal well with any breathing problems.

Due to modern, lightweight oxygen concentrators, seniors can keep using oxygen while being active. Older people recovering from surgery or who have infections are more likely to have their oxygen levels drop, requiring additional oxygen therapy at home. With the change to home care as an alternative to overcrowded hospitals, oxygen concentrators have become very important. Many older patients choose these medical devices because they are useful, cost less and make life better. So, the rise in elderly people worldwide is significantly boosting the oxygen concentrator industry, leading businesses to make products that meet the particular needs of the elderly.

The high cost of advanced oxygen concentrators can limit access, especially in low-income regions.

Because advanced oxygen concentrators are expensive, they are less accessible in low-income places across the world. Some models such as those that are small or have two types of flow, can cost a lot to purchase and maintain. For many people in developing countries, continuing to use such advanced devices is a major challenge, despite the expanding need for them. The financial challenge of medical care influences both people and smaller health service providers with small budgets. A lack of insurance or government support for these devices in many areas prevents patients from getting help.

Starting up the import and maintenance of oxygen concentrators is very costly for under-resourced healthcare systems. Equipment upkeep, spare part options and personnel who are skilled at operating and fixing the machines push up the total cost. Because of these barriers, medical facilities in such areas still depend heavily on older systems, for example, oxygen cylinders. As a result, using improved and safer technology in concentrators is more difficult and it also delays enhancements in long-term respiratory care. If producers do not try to lower the cost or create less expensive devices, many in need will not be able to buy them. The high price of oxygen therapy forms a major barrier to equal access for everyone on the planet.

Technological innovations like battery-operated and noise-free concentrators are creating new market potential.

Improvements in battery technology and quiet operation have introduced added opportunities for the global oxygen concentrators market. Since traditional concentrators are large, loud and use constant power, they cannot be used in settings outside a hospital. If staying mobile is important, battery-powered models are well suited for elderly patients and people living very active lives who must use oxygen all the time. The compact nature of these units ensures people can enjoy their treatment without giving up their freedom of movement. Patients living in remote locations or on the move will find this important, as reliable power is not always available to them.

Noise-free concentrators help home patients and those using equipment during the night, making them more comfortable. Less sound makes these devices ideal for use in places where it’s important to keep things quiet such as hospitals and nursing homes. Not only do advanced tools enhance the user experience, but they also inspire in a wide variety of areas in healthcare. Besides, continuous efforts to advance energy saving and increase the hours batteries can work are also boosting the market’s expansion. When people become more tuned in to the good things about advanced tech, manufacturers can target buyers at both ends of the price spectrum. Providing personalized products that blend into a patient’s lifestyle helps businesses build a bigger customer base and make more money as healthcare needs develop.

Rising healthcare investments in emerging economies are expanding access to oxygen therapy.

Higher amounts of money being invested in healthcare in other parts of the world create a great chance for the oxygen concentrators market. To boost their healthcare systems, countries in Asia, Africa and Latin America are focusing more on getting hold of essential medical devices such as oxygen therapy machines. There is an increasing number of funds being used by governments and private groups to develop hospitals, clinics and home-care services. Expanded medical services mean there is now greater demand for oxygen concentrators, and this is more obvious in places where respiratory problems are common. A greater level of awareness about respiratory care, among patients and healthcare personnel, reflects strongly on the demand for oxygen which positively impacts market development.

Because of better healthcare funding in emerging economies, they are now able to buy oxygen concentrators at home and on the go. Many times, these investments rely on healthcare and global initiatives to boost patient care, especially in areas where it is needed most. As a result of the COVID-19 pandemic, nations around the world recognized how vital oxygen supply is in critical care and made efforts to be well-prepared for new healthcare challenges. Nearby manufacturing and distribution networks are increasing, so oxygen concentrators are now more available and reasonably priced. Due to this change, patients get quick treatment, and it allows global and regional companies to become more visible in the market. Successful improvements in healthcare across the area promise to open many new avenues and lead to more adoption and lasting demand for oxygen concentrators.

Segment Analysis

Based on product type, the Oxygen Concentrators Market is segmented into Portable Oxygen Concentrators (POC) and Stationary Oxygen Concentrators. Because they are portable and easy to carry, portable oxygen concentrators are suited to patients who are travelling or otherwise on the move. Instead, stationary oxygen concentrators, unlike portable versions, are meant for use only at home or in a hospital and offer more oxygen, but they are not as easy to move. At present, sales in the portable oxygen concentrator segment are the largest. More people choosing home healthcare, patient needs for comfort and new technologies in portability and batteries have caused this segment to expand quickly.

Based on technology, the Oxygen Concentrators Market is segmented into Continuous Flow, Pulse Dose, and Dual Flow systems. A continuous flow machine provides regular oxygen, particularly for those whose oxygen levels must be maintained for sleep or when they receive care at a hospital or clinic. Only when the patient takes a breath does pulse dose technology provide oxygen which makes it both power-efficent and suitable for use in portable devices. A dual flow system combines continuous and pulse injection into one machine, allowing for various applications. Pulse dose technology is currently the biggest part of the market since it is more energy efficient, compact and delivers longer battery life than other types, all important traits for convenient oxygen therapy.

Regional Analysis

The North American oxygen concentrators market is well-developed, driven by a high prevalence of respiratory diseases, strong healthcare infrastructure, and widespread awareness of advanced medical devices. The fact that major manufacturers are here, along with the high healthcare costs, has helped the region become a leader in portable and house oxygen use. Insurance for respiratory care devices and rising demand among old people are factors supporting the market. Many Americans and Canadians are choosing home healthcare, so there is a rise in the popularity of small and convenient oxygen concentrators. The growth of this market is being supported by government involvement and required approvals. Technological advancements, such as integration with smart monitoring systems and mobile apps, are further enhancing user convenience and driving market adoption across North America.         

The Asia Pacific oxygen concentrators market is expanding rapidly, fueled by increasing healthcare awareness, growing respiratory health concerns, and improvements in medical infrastructure. Since pollution levels and respiratory diseases are on the rise in China, India and Japan, there is now greater demand for oxygen concentrators there. As a result of the pandemic, it became clear that more people need easy access to oxygen therapy which led to more government and private support for this area. Manufacturers in developing countries are also making oxygen concentrators more economical for their markets. With an ageing population and improved access to healthcare, the region offers a big chance for market development

Competitive Landscape

The market for oxygen concentrators involves several main competitors aiming to develop their position by making new products, teaming up with others and selling abroad. Philips Healthcare, Inogen, Invacare Corporation, Drive DeVilbiss Healthcare and CAIRE Inc. have the largest share in the market because they offer a variety of both stationary and portable concentrators. These firms aim to perfect their products’ efficiency, ease of carrying and simplicity to match the rising need for at-home and travel oxygen. There are also new types of companies, both local and international, joining the market and selling affordable and compact devices. Healthcare companies are growing in popularity because of partnerships with hospitals, e-commerce sites and distributors.

Oxygen Concentrators Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Recent Developments:

• In October 2024, Inogen, Inc. launched Inogen Rove 4 Portable Oxygen Concentrator in the U.S. market. Offering innovative respiratory products for use in the homecare setting.

Report Coverage:

By Product Type

• Portable Oxygen Concentrators (POC)
• Stationary Oxygen Concentrators

By Technology

• Continuous Flow
• Pulse Dose
• Dual Flow

By Delivery System

• Compressed Gas Systems
• Liquid Oxygen Systems
• Oxygen Concentrator Systems

By Power Source

• Electric Powered
• Battery Powered
• Solar Powered

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Sleep Apnea
• Respiratory Distress Syndrome
• Pneumonia
• Cystic Fibrosis
• Other Respiratory Conditions

By End User

• Hospitals
• Homecare Settings
• Ambulatory Surgical Centers
• Long-Term Care Facilities
• Military & Emergency Services

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Philips Healthcare
• Inogen, Inc.
• Invacare Corporation
• Drive DeVilbiss Healthcare
• CAIRE Inc.
• Nidek Medical Products, Inc.
• O2 Concepts, LLC
• GCE Group
• Teijin Limited
• Chart Industries, Inc.
• Precision Medical, Inc.
• Linde plc
• Beijing Shenlu Medical Device Co., Ltd.
• Longfian Scitech Co., Ltd.
• SysMed (China) Co., Ltd.

Frequently Asked Questions (FAQs)